U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07094711) titled 'Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)' on July 23.
Brief Summary: The purpose of this study is to find out if the Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine can be used safely to treat Mycobacterium avium complex (MAC) lung disease.
Researchers will compare responses from patients with MAC lung disease after receiving an injection of BCG or placebo (a look-alike substance that contains no drug)
Participants in the study:
* Receive a BCG or placebo injection at UVA study center on Day 0
* Come to UVA study center on Day 60
* Come to UVA study center at the end of the ...